Jeil Pharma Holdings Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Seung-Soo Han
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 66.0% |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
Is Jeil Pharma Holdings Inc (KRX:002620) A Smart Choice For Dividend Investors?
Mar 25
These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively
Feb 27What Percentage Of Jeil Pharma Holdings Inc (KRX:002620) Shares Do Insiders Own?
Jan 23
Jeil Pharma Holdings (KRX:002620) Has Compensated Shareholders With A 56% Return On Their Investment
Dec 28Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet
Nov 23CEO
Seung-Soo Han (76 yo)
no data
Tenure
Seung Soo Han serves the Chairman of the Board and Chief Executive Officer of Jeil Pharma Holdings Inc (formerly known as Jeil Pharmaceutical Co., Ltd.)